| Financial Year |
March 31 2023 |
| Monetary Funds |
1,085,942,106.20 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
12,746,693.80 |
| Accounts Receivable |
950,509,208.74 |
| Advances to Suppliers |
68,242,469.44 |
| Other Receivables |
133,251,942.13 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
106,071,953.19 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
6,609,572.73 |
| Other Current Assets |
32,211,179.44 |
| Total Current Assets |
4,160,823,182.06 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
29,150,911.64 |
| Long-term Equity Investment |
479,880,747.99 |
| Investment Properties |
-- |
| Fixed Assetes |
487,697,889.37 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,145,579,047.10 |
| R&D expenses |
81,621,202.92 |
| Goodwill |
596,225,927.81 |
| Long-Term Deferred and Prepaid Expenses |
16,270,184.56 |
| Deferred Income Tax Assets |
239,694,833.81 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
3,582,473,092.71 |
| Total Assets |
7,743,296,274.77 |
| Short-Term Loans |
31,841,908.33 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
525,232,516.93 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
118,422,431.92 |
| Taxes Payable |
290,961,339.17 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
206,584,436.44 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
48,105,415.27 |
| Other Current Liabilities |
28,161,708.49 |
| Sub-Total of Current Liabilities |
1,499,256,352.80 |
| Long-term Loans |
-- |
| Bonds Payable |
963,926,483.27 |
| Long-Term Accounts Payable |
48,322,100.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
35,921,211.76 |
| Deferred Income Tax Liabilities |
71,211,560.42 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,152,745,497.42 |
| Total Liabilities |
2,652,001,850.22 |
| Paid-In Capital(Or Share Stock) |
2,147,729,781.00 |
| Capital Surplus |
709,025,531.19 |
| Surplus Reserve |
225,669,637.75 |
| LESS:Treasury Stock |
120,644,086.54 |
| Undistributed Profits |
2,054,934,342.91 |
| Minority Stockholder's Interest |
-28,342,388.05 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,119,636,812.60 |
| Owner's Equity（Stockholder's Equity） |
5,091,294,424.55 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,743,296,274.77 |
